1.7 times that seen in placebo-treated patients. Over abilify off label uses course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to abilify off label uses rate of about 2.6% in abilify off label uses placebo group. Although the causes of death abilify off label uses varied, most of the deaths abilify off label uses to be either cardiovascular (eg, heart failure.

or PKU, ABILIFY® DISCMELT™ (aripiprazole) contains abilify off label uses abilify off label uses abilify off label uses approved for pediatric patients with abilify off label uses depressive disorder (MDD).This site abilify off label uses intended abilify off label uses residents of abilify off label uses United States abilify off label uses are 18 years and older.Please see U.S. FULL PRESCRIBING INFORMATION, including Boxed WARNINGS, and Medication Guide.IMPORTANT SAFETY INFORMATION and INDICATION for ABILIFY® (aripiprazole)INDICATIONS: ABILIFY is indicated abilify off label uses treatment to antidepressants for major depressive disorder in adultsAcute and maintenance treatment of abilify off label uses with manic or mixed episodes associated with Bipolar I abilify off label uses treatment of pediatric patients 10 abilify off label uses 17 years of age with manic or mixed episodes associated with Bipolar I DisorderTreatment of schizophrenia in adults and adolescents 13 to 17 abilify off label uses of ageIMPORTANT SAFETY INFORMATION:Elderly people with psychosis related to abilify off label uses (for example, an inability abilify off label uses perform daily activities as a result of increased memory loss), treated with atypical.

be periodically reassessed to determine the need for maintenance treatment.AdolescentsThe efficacy abilify off label uses ABILIFY for the maintenance treatment.